The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice

Canadian Journal of Cardiology

Volumn 32, Issue 3, 2016, Pages 296-310

  Howlett, Jonathan G ^a   Chan, Michael ^b   Ezekowitz, Justin A ^c   Harkness, Karen ^d   Heckman, George A ^e   Kouz, Simon ^f   Leblanc, Marie Hélène ^g   Moe, Gordon W ^h   O'Meara, Eileen ⁱ   Abrams, Howard ^j   Ducharme, Anique ⁱ   Grzeslo, Adam ^d   Hamilton, Peter G ^c   Koshman, Sheri L ^c   Lepage, Serge ^k   McDonald, Michael ^l   McKelvie, Robert ^d   Rajda, Miroslaw ^m   Swiggum, Elizabeth ⁿ   Virani, Sean ^o   Zieroth, Shelley ^p   more..

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF WATERLOO   (Canada)

^f UNIVERSITÉ LAVAL   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^l UNIVERSITY HEALTH NETWORK   (Canada)

^m DALHOUSIE UNIVERSITY   (Canada)

ⁿ ROYAL JUBILEE HOSPITAL   (Canada)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p ST BONIFACE GENERAL HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; IVABRADINE; MINERALOCORTICOID ANTAGONIST; NITRIC ACID DERIVATIVE; SACUBITRIL PLUS VALSARTAN; SPIRONOLACTONE;

ARTICLE; BLOOD PRESSURE; CREATININE BLOOD LEVEL; DIURETIC THERAPY; GOUT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART SURGERY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPONATREMIA; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; PATIENT REFERRAL; PRACTICE GUIDELINE; SELF CARE; UREA NITROGEN BLOOD LEVEL; URINARY FREQUENCY; URINE INCONTINENCE; CANADA; CARDIOLOGY; DISEASE MANAGEMENT;

CANADA; CARDIOLOGY; DISEASE MANAGEMENT; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84959535215     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.06.019     Document Type: Article

References (66)

1. Arnold J.M., Howlett J.G., Dorian P., et al. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol 2007, 23:21-45.
2. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006, 22:23-45.
3. Moe G.W., Ezekowitz J.A., et al. The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization. Can J Cardiol 2014, 30:249-263. Canadian Cardiovascular Society Heart Failure Management Primary Panel.
4. Howlett J.G., McKelvie R.S., Arnold J.M., et al. Canadian Cardiovascular Society Consensus Conference Guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009, 25:85-105.
5. Howlett J.G., McKelvie R.S., Costigan J., et al. The 2010 Canadian Cardiovascular Society Guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol 2010, 26:185-202.
6. Malcom J., Arnold O., Howlett J.G., et al. Canadian Cardiovascular Society Consensus Conference Guidelines on heart failure-2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol 2008, 24:21-40.
7. McKelvie R.S., Moe G.W., Cheung A., et al. The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol 2011, 27:319-338.
8. McKelvie R.S., Moe G.W., Ezekowitz J.A., et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 2013, 29:168-181.
9. Moe G.W., Ezekowitz J.A., O'Meara E., et al. The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications. Can J Cardiol 2015, 31:3-16.
10. Arnold M., Howlett J., Liu P., et al. The Canadian Cardiovascular Society (CCS) heart failure consensus conference program: shaping the future of heart failure management in Canada. Eur J Heart Fail Suppl 2008, 7:17.
11. Howlett J.G., McKelvie R., Ross H., et al. The Canadian Cardiovascular Society Heart Failure Guidelines implementation: initial results from the National Workshop Initiative. Eur J Heart Fail Suppl 2008, 7:22.
12. Arnold JMO, Ignazweski A, Howlett J; on behalf of the Canadian Heart Failure Network Inc. Changes in drug utilization in patients referred to outpatient heart failure clinics in Canada between 1999 and 2007. J Am Coll Cardiol 2009;53. A166.
13. Howlett J.G., Johnstone D.E., Sketris I., et al. Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study. Can J Cardiol 2003, 19:439-444.
14. Howlett JM, Harkness K, Heckman G, et al. Survey for Practical HF Guidelines Implementations by Canadian Experts. Available at: Accessed August 26, 2015. http://ccs.ca/en/guidelines/guidelines-library.
15. Ross H., Howlett J., Arnold J.M., et al. Treating the right patient at the right time: access to heart failure care. Can J Cardiol 2006, 22:749-754.
16. Canadian Cardiovascular Society. Mobile apps. Available at: Accessed May 15, 2015. http://www.ccs.ca/index.php/en/resources/mobile-apps.
17. Funck-Brentano C., van Veldhuisen D.J., van de Ven L.L., et al. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial. Eur J Heart Fail 2011, 13:765-772.
18. Willenheimer R., van Veldhuisen D.J., Silke B., et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005, 112:2426-2435.
19. Canadian Cardiovascular Society. Heart Failure medication titration App and Heart Failure Guidelines app. Available at: Accessed May 15, 2015. http://www.ccs.ca/index.php/en/resources/mobile-apps.
20. Canadian Cardiovascular Society. Heart Failure Pocket Guides. Available at: Accessed May 15, 2015. http://www.ccs.ca/index.php/en/resources/pocket-guides.
21. Canadian Cardiovascular Society. Heart Failure Guidelines Educational Slide Decks. Available at: Accessed May 15, 2015. http://www.ccs.ca/index.php/en/resources/educational-slide-decks.
22. Amir O., Hassan Y., Sarriff A., et al. Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases. Pharm World Sci 2009, 31:387-393.
23. Kuijvenhoven M.A., Haak E.A., Gombert-Handoko K.B., Crul M. Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia. Int J Clin Pharm 2013, 35:1099-1104.
24. Pitt B., Bakris G., Ruilope L.M., et al. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation 2008, 118:1643-1650.
25. Zannad F., McMurray J.J., Drexler H., et al. Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail 2010, 12:617-622.
26. Young J.B., Dunlap M.E., Pfeffer M.A., et al. Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation 2004, 110:2618-2626.
27. Zannad F., McMurray J.J., Krum H., et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011, 364:11-21.
28. Meredith P.A., Ostergren J., Anand I., et al. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity). Program. J Am Coll Cardiol 2008, 52:2000-2007.
29. Akosah K.O., McHugh V.L., Mathiason M.A., et al. Closing the heart failure management gap in the community: managing hypotension and impact on outcomes. J Card Fail 2009, 15:906-911.
30. Mak G., Murphy N.F., Ali A., et al. Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?. J Card Fail 2008, 14:555-560.
31. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006, 296:2217-2226.
32. Rouleau J.L., Roecker E.B., Tendera M., et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 2004, 43:1423-1429.
33. Metra M., Torp-Pedersen C., Swedberg K., et al. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 2005, 26:2259-2268.
34. Castagno D., Skali H., Takeuchi M., et al. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am Coll Cardiol 2012, 59:1785-1795.
35. Basuray A., French B., Ky B., et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation 2014, 129:2380-2387.
36. Dunlay S.M., Roger V.L., Weston S.A., Jiang R., Redfield M.M. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail 2012, 5:720-726.
37. Clarke C.L., Grunwald G.K., Allen L.A., et al. Natural history of left ventricular ejection fraction in patients with heart failure. Circ Cardiovasc Qual Outcomes 2013, 6:680-686.
38. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992, 327:685-691.
39. Hopper I., Samuel R., Hayward C., Tonkin A., Krum H. Can medications be safely withdrawn in patients with stable chronic heart failure? Systematic review and meta-analysis. J Card Fail 2014, 20:522-532.
40. Grewal J., Silversides C.K., Colman J.M. Pregnancy in women with heart disease: risk assessment and management of heart failure. Heart Fail Clin 2014, 10:117-129.
41. Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol 2014, 64:1629-1636.
42. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005, 111:2050-2055.
43. Liu C., Zhao Q., Zhen Y., et al. Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study. Can J Cardiol 2013, 29:1048-1054.
44. Velazquez E.J., Lee K.L., Deja M.A., et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011, 364:1607-1616.
45. Jones R.H., Velazquez E.J., Michler R.E., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009, 360:1705-1717.
46. Martocchia A., Frugoni P., Indiano I., et al. Screening of frailty in elderly patients with disability by the means of Marigliano-Cacciafesta polypathology scale (MCPS) and Canadian Study of Health and Aging (CSHA) scales. Arch Gerontol Geriatr 2013, 56:339-342.
47. Chan M., Tsuyuki R. Heart failure in the elderly. Curr Opin Cardiol 2013, 28:234-241.
48. Shah R.U., Tsai V., Klein L., Heidenreich P.A. Characteristics and outcomes of very elderly patients after first hospitalization for heart failure. Circ Heart Fail 2011, 4:301-307.
49. Manzano L., Babalis D., Roughton M., et al. Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail 2011, 13:528-536.
50. Braunstein J.B., Anderson G.F., Gerstenblith G., et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003, 42:1226-1233.
51. Tanner C.E., Fromme E.K., Goodlin S.J. Ethics in the treatment of advanced heart failure: palliative care and end-of-life issues. Congest Heart Fail 2011, 17:235-240.
52. McLennan S.N., Mathias J.L., Brennan L.C., Stewart S. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol 2011, 24:33-38.
53. Nasreddine Z.S., Phillips N.A., Bedirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699.
54. Moller H.J. Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 2001, 251(suppl 2):II13-20.
55. Schein R.L., Koenig H.G. The Center for Epidemiological Studies-Depression (CES-D) Scale: assessment of depression in the medically ill elderly. Int J Geriatr Psychiatry 1997, 12:436-446.
56. Smarr K.L., Keefer A.L. Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res 2011, 63(suppl 11):S454-S466.
57. Newman S., Steed L., Mulligan K. Self-management interventions for chronic illness. Lancet 2004, 364:1523-1537.
58. Riegel B., Moser D.K., Anker S.D., et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation 2009, 120:1141-1163.
59. Lainscak M., Blue L., Clark A.L., et al. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011, 13:115-126.
60. Buck H.G., Harkness K., Wion R., et al. Caregivers' contributions to heart failure self-care: a systematic review. Eur J Cardiovasc Nurs 2015, 14:79-89.
61. Harkness K., Spaling M.A., Currie K., Strachan P.H., Clark A.M. A systematic review of patient heart failure self-care strategies. J Cardiovasc Nurs 2015, 30:121-135.
62. Riegel B., Jaarsma T., Stromberg A. A middle-range theory of self-care of chronic illness. ANS Adv Nurs Sci 2012, 35:194-204.
63. Barnason S., Zimmerman L., Young L. An integrative review of interventions promoting self-care of patients with heart failure. J Clin Nurs 2012, 21:448-475.
64. Graven L.J., Grant J.S. Social support and self-care behaviors in individuals with heart failure: an integrative review. Int J Nurs Stud 2014, 51:320-333.
65. Siabani S., Leeder S.R., Davidson P.M. Barriers and facilitators to self-care in chronic heart failure: a meta-synthesis of qualitative studies. Springerplus 2013, 2:320.
66. Zavertnik J.E. Self-care in older adults with heart failure: an integrative review. Clin Nurse Spec 2014, 28:19-32.